Intervention: Radiotherapy combined with tislelizumab and anlotinib
Found 4 matching trials
Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus
PHASE2
For HCC patients with PVTT who the researchers believe can benefit from rad...